Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Stock Report

| More

Panacea Biotec announces launch of ViLACT for treatment of Uncontrolled Type 2 Diabetes Mellitus patients

Posted On: 2019-12-10 17:32:02

Panacea Biotec has announced the launch of brand ViLACT in India. ViLACT is used in the treatment of Uncontrolled Type 2 Diabetes Mellitus patients with HbAlc >6.5%.

ViLACT is available in four formulations:

1. ViLACT Vildagliptin 50 mg Tablet.
2. ViLACTM 500 Vildagliptin 50 mg + Metformin HCL500 mg Tablet.
3. ViLACT M 850 Vildagliptin 50 mg + Metformin HCL850 mg Tablet.
4. ViLACTM 1000 Vildagliptin 50 mg + Metformin HCL1000 mg Tablet.

The total market size of this molecule and its combination is INR 969 Crore as per AIOCD MAT October '2019 and is growing at the rate of 4%. Vildagliptin product patent (IN 212815) in India has expired on 09th December '2019. Vildagliptin is a new oral antidiabetic agent that enhances pancreatic islet cell responsiveness to glucose, is an incretin enhancer, a potent and selective inhibitor of dipeptidyl peptidase-4 (DPP-4), the enzyme responsible for the rapid degradation of the incretin hormones glucagon-like peptide-1 (GLP-l) and glucose-dependent insulinotropic peptide (GIP). This activity increases levels of active incretins and enhances pancreatic islet α- and β-cell responsiveness to glucose, thus improving insulin secretion and reducing inappropriate glucagon production, improving insulin sensitivity, improving postprandial lipid and lipoprotein metabolism, and reducing fasting and prandial glucose and HbAlc.

Speaking on the occasion Dr. Rajesh Jain, Managing Director said: "Diacar Strategic Business Unit (SBU) has launched ViLACT brand family. This will open up a new segment for accelerated growth of the SBU.

I am pleased to share that during pre-launch activity that started in the month of October '2019, an innovative campaign was launched to protect our environment wherein 10,000 Doctors from all over India participated by pledging I "ViL ACT" to save the environment by planting over 10,000 plants, saying NO to plastic using Khadi bags, in the process giving boost to MSME sector as part of promoting use of Khadi.

In NewYear 2020, our aim is to reach 100,000 Doctors and plant over 100,000 saplings and we have created a website on this occasion.

Mr. Susheel Umesh, Chief Executive, Domestic Formulation said the ViLACT brand will be an affordable, high quality medicine in the armamentarium of a physician treating patients with Diabetes. The patients have always been and will continue to be the center of our business. The Physician needs a lot of options to bring down the burden of Diabetes and we with the ViLACT range will continue to support the patient and physician in this journey."

Shares of PANACEA BIOTEC LTD. was last trading in BSE at Rs.114.7 as compared to the previous close of Rs. 115.85. The total number of shares traded during the day was 13067 in over 513 trades.

The stock hit an intraday high of Rs. 122.3 and intraday low of 114.5. The net turnover during the day was Rs. 1540730.

Source: Equity Bulls

Click here to send ur comments or to

Other Headlines:

Blue Dart Sales at Rs. 855.64 crores for the Quarter October - December 2019

L&T Finance Holdings Ltd consolidated Q3 net profit up at Rs. 591.03 crore

RIL Q3 FY20 consolidated PAT at Rs. 11640 crore

Country's best-selling multi-purpose van Maruti Suzuki Eeco is now BS6 compliant

Aegon Life Insurance Company partners with Saksoft to accelerate digital transformation

CRISIL Rating on the Rs.5000 Crore Infrastructure Bonds of Axis Bank Limited

Capri Global Capital Ltd to divest stake in ARC arm

Mahindra First Choice Wheels Ltd to acquire

Mercator Ltd has sold vessel for Rs. 49.54 crore

Yash Chemex Ltd to apply for IPO of Hindprakash Industries Ltd

HCL Technologies Ltd Board approves Dividend of Rs. 2 for FY2019-20

TCS board declares third interim dividend of Rs. 5 for FY2020

United Drilling Tools Ltd launched truck mounted winch with crane

APL Apollo Tubes Limited approves allotment of Commercial Paper of Rs 20 Crores

Quick Heal Technologies Ltd gets favorable verdict from CESTAT

Acrysil Limited Signs An Agreement With Farah Ali Khan For Brand STERNHAGEN

IOB files insolvency application against Ramky Infrastructure subsidiary

HCL Technologies Ltd posts consolidated net profit of Rs. 2944 crores in Q3 FY20

L&T Technology Services Ltd reports consolidated PAT of Rs. 204.1 crore in Q3

TCS Q3 FY20 consolidated PAT at Rs. 8118 crore

AVANTEL Ltd Q3 net profit at Rs. 2.90 crore

Accel Ltd to acquire 75% of Computer Factory India Pvt. Ltd.

Piramal Divests its DRG Business for US$950 Million

Rubfila International Ltd to acquire 50% of Premier Tissues India Ltd

QGO Finance Ltd to raise Rs. 11 crore through NCDs

AMAL Ltd Q3 net profit at Rs. 1.36 crore

Trident Limited received 'TEXPROCIL Export Awards 2018-2019'

Manomay Tex India Limited wins TEXPROCIL Export Award 2018-19

Apollo Micro Systems Limited bags order of Rs. 18.10 crores

Kalpataru Power Transmission Ltd successfully commissions element 1 of Alipurduar Transmission Ltd

Srikalahasthi Pipes Ltd commences commercial operations of ferro alloys unit

Karnataka Bank's net profit at Rs. 123.14 crores in Q3 FY2020

Rallis reports positive performance with Consolidated Revenues at Rs. 534 Crores, up 28% QoQ Consolidated PAT at Rs. 38 Crores, up 177% QoQ

5paisa Capital - Income for Q3FY20 at Rs. 2,678 Lakhs (up 48% y-o-y), and for 9MFY20 at Rs. 7,289 Lakhs (up 83% y-o-y)

The Hon'ble Supreme Court of India lifts suspension of the Environment Clearance on GMR Goa International Airport

Bharti Airtel evaluates filing curative petition on AGR verdict

CARE reaffirms FD rating of Gillanders Arbuthnot and Company Limited

Dishman Carbogen Amcis Ltd Board approves Buy-back of equity shares upto Rs. 150 through market purchase

Hitech Corporation Ltd to discontinue operations at Sarigam unit

HIL Ltd to sell calcium silicate insulation products division

TATA Metaliks Ltd Q3 net profit jumps to Rs. 45.91 crores

Karnataka Bank Ltd Q3 net profit at Rs. 123.14 crores

South Indian Bank Ltd posts PAT of Rs. 90.54 crores in Q3 FY2020

Rallis India Ltd reports consolidated net profit of Rs. 38.14 crores in Q3

Cyient Limited Q3 consolidated PAT up at Rs. 108.3 crore

IndiGo strengthens connectivity between India and the Middle-East with Dammam as its 24th international destination

TCS Named a Leader in Healthcare Digital Services by Avasant

Wipro Ventures Announces $150M Fund II to Invest in Emerging Digital Enterprise Software Leaders

Sterling and Wilson Solar Limited wins 'Utility-Scale Solar Project of the Year' at Middle East Solar Awards 2020

Ind-Ra downgrades rating of Rico Auto Industries Ltd

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019